Company profile for Leukos Biotech

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Leukos Biotech is a spin-off company form the Josep Carreras Leukaemia Research Institute.We focus on developing new treatments and diagnostic tools for Leukaemia.We have identified a new therapeutic target against Leukemic Stem Cells in AML which will be validated, using a repurposed small molecule, in a Phase II clinical trial starting at the end of 2017. The study will also cover the diagnosis and prognosis of AML patients ...
Leukos Biotech is a spin-off company form the Josep Carreras Leukaemia Research Institute.We focus on developing new treatments and diagnostic tools for Leukaemia.We have identified a new therapeutic target against Leukemic Stem Cells in AML which will be validated, using a repurposed small molecule, in a Phase II clinical trial starting at the end of 2017. The study will also cover the diagnosis and prognosis of AML patients according to the expression of this biomarker in blood.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Spain
Address
Address
Muntaner 383, 3º2º 08021 Barcelona Spain
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

AMWC Asia-TDAC

AMWC Asia-TDAC

Not Confirmed

envelop Contact Supplier

AMWC Asia-TDAC

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20241001468319/en

BUSINESSWIRE
01 Oct 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty